01061 ESSEX BIO-TECH
Trading Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.81X | Oper Margin | 23.0% |
|---|---|---|---|
| LT Debt/Equity | 5.4% | Net Margin | 18.4% |
| Total Debt/Equity | 8.8% | Return on Equity | 14.5% |
| Price/Book | 1.39X | Return on Assets | 10.3% |
| (HKD 5.200) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 307.22 | 275.26 | 225.41 | 345.97 | 218.93 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +11.6 | +22.1 | -34.9 | +58.0 | -27.6 |
| Earnings Per Share (HKD) | 0.541 | 0.483 | 0.393 | 0.6 | 0.379 |
| Earnings Per Share Growth (%) | +12.2 | +22.9 | -34.6 | +58.4 | -27.5 |
| Dividend Per Share (HKD) | 0.120 | 0.090 | 0.065 | 0.095 | 0.050 |
| P/E* (X) | 9.60 | 10.77 | 13.24 | 8.67 | 13.72 |
| Yield (%) | 2.31 | 1.73 | 1.25 | 1.83 | 0.96 |
| Dividend Share (%) | 22.16 | 18.65 | 16.55 | 15.83 | 13.20 |
| Book NAV (HKD) | 3.745 | 3.389 | 3.029 | 3.013 | 2.472 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (HKDMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 1,670 | 1,737 | -3.9 | 1,318 |
| Operating Result | 378.411 | 347.655 | +8.8 | 260.537 |
| Associates | -2.911 | -1.641 | +77.4 | -0.194 |
| Profit Before Taxation | 375.5 | 346.014 | +8.5 | 260.343 |
| Taxation | 68.278 | 70.755 | -3.5 | 34.931 |
| Profit /( Loss) After Taxation | 307.222 | 275.259 | +11.6 | 225.412 |
| Net Profit | 307.222 | 275.26 | +11.6 | 225.411 |
| Earnings Per Share () | 0.5414 | 0.4827 | +12.2 | 0.3927 |
| Dividend Per Share () | 0.1200 | 0.0900 | +33.3 | 0.0650 |
| Announcement Date | 2025-03-26 | 2024-03-18 | NA | 2023-03-08 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
